GSK3052230
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3052230, covering 2019-02-11 to 2019-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling [Phase 1]